90 likes | 290 Views
Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63. Characteristics of selected major statin trials. Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63. Updated meta-analysis of major statin trials that assessed the effect of statins on fatal and non-fatal stroke.
E N D
Characteristics of selected major statin trials Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
Updated meta-analysis of major statin trials that assessed the effect of statins on fatal and non-fatal stroke Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
Updated meta-analysis of major statin trials that assessed the effect of statins on fatal stroke Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
Updated meta-analysis of major statin trials that assessed the effect of statins on haemorrhagic stroke Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
Association between reduction in LDL cholesterol concentration with stroke incidence among the major statins trials Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
Meta-analysis of statin trials that assessed the effect of intensive lipid-lowering therapy versus standard statin therapy on incidence of fatal and non-fatal stroke and on major cardiovascular events Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63